Glioblastoma

CHICAGO — Adding anlotinib to standard temozolomide-based chemoradiotherapy significantly extended PFS for newly diagnosed glioblastoma in a randomized phase 2 trial, according to findings presented at ASCO Annual Meeting.

An anthelminthic drug commonly used for pinworm infections could be repurposed to treat a deadly form of skin cancer, according to early study results.

SAN DIEGO — An early-initiation telehealth protocol for advanced care planning was feasible and registered a high degree of satisfaction for patients with glioblastoma and their care partners and providers, according to a poster.

In 2024, both Kate Middleton, Princess of Wales, and King Charles III told the world they had cancer.

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel immunotherapy regimen for glioblastoma developed based on his own studies.

Psilocybin-assisted psychotherapy significantly improved a range of psychiatric symptoms among people with cancer, according to research published in Nature Mental Health.

Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with pancreatic cancer or other gastrointestinal malignancies.

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.

It’s only the beginning.

The addition of veliparib to adjuvant temozolomide failed to improve OS for patients with newly diagnosed, MGMT-hypermethylated glioblastoma, according to randomized phase 2/phase3 study results.